13F HOLDINGS REPORT
Foresite Capital Management V, LLC
Quarter ended Q4 2023 · Filed November 13, 2023 · Accession 0001104659-23-117294
Total Value
$62.7M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Hims & Hers Health, Inc. | HIMS | 3,733,381 | $23.5M | 37.47% |
| 2 | Disc Medicine, Inc. | IRON | 243,513 | $11.4M | 18.25% |
| 3 | Theseus Pharmaceuticals, Inc. | 88369M101 | 4,108,796 | $11.1M | 17.63% |
| 4 | Aclaris Therapeutics, Inc. | ACRS | 1,258,243 | $8.6M | 13.75% |
| 5 | Kinnate Biopharma Inc. | 49705R105 | 3,525,957 | $4.9M | 7.88% |
| 6 | Compass Therapeutics, Inc. | CMPX | 1,246,977 | $2.5M | 3.92% |
| 7 | Pharvaris N.V. | PHVS | 33,142 | $691,674 | 1.10% |